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ABSTRACT 
In spite of vigorous research efforts to date the induction of bone formation by 
macroporous coral-derived constructs when implanted heterotopically in the rectus 
abdominis muscle of the non-human primate Chacma baboon Papio ursinus has not yet 
been resolved and needs to be assigned. More importantly, the apparent redundancy of 
molecular signals singly initiating the induction of bone formation in primate species and 
the heterotopic induction of endochondral bone formation by the mammalian recombinant 
human transforming growth factor –β3 (rhTGF-β3) isoform have not yet been assigned and 
need to be mechanistically resolved. Using the rectus abdominis muscle of Papio ursinus 
the study sought to molecularly determine how coral-derived macroporous constructs and 
doses of the hTGF-β3 isoform initiate the induction of bone formation. To elucidate the 
function of osteoclastogenesis and Ca
2+
, biomimetic coral-derived 7% 
hydroxyapatite/calcium carbonate (7% HA/CC) devices were supplemented either with 
240 μg zoledronate bisphosphonate, an osteoclast binding antagonist, or 500 μg of the 
calcium channel blocker verapamil hydrochloride. Additionally but in separate coral-
derived bioreactors, 125 μg rhTGF-β3 and/or 125 μg hNoggin were added to answer the 
question of how TGF-β3 induces bone formation. All devices were then subsequently 
implanted within heterotopic sites of the rectus abdominis muscle of 6 Papio ursinus and 
left in vivo for 15, 60 and 90 days. Harvested specimens were subjected to 
histomorphometrical and quantitative reverse transcription polymerase chain reaction 
(qRT-PCR) analysis. Collagen Type IV expression supported by extensive vascularisation 
was detected and observed respectively in all implants after 15 days in vivo. Importantly 
the zoledronate treated specimens possessed delayed tissue patterning and morphogenesis,  
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an observation not as pronounced as within the verapamil hydrochloride treated specimens. 
However, both treatment modalities showed a lack or minimal bone formation. The gene 
expression experiments revealed that Noggin was elevated whereas bone morphogenetic 
protein-2 (BMP-2) was greatly downregulated in the verapamil or zoledronate treated 
devices, indicating that bone formation by macroporous coral-derived devices is through 
the BMP-pathway. Therefore Ca
2+
 release may be the driving force behind the bone 
induction mechanism by both regulating stem cell differentiation and the BMP-pathway. 
 
In 7% HA/CC constructs preloaded with 125ug hNoggin there was downregulation of 
BMP-2 and lack of TGF-β3 activity. Minimal bone formation characterised the hNoggin 
treated bioreactor. The hTGF-β3/hNoggin treated devices exhibited BMP-2 upregulation on 
day 90 and significant Noggin downregulation on day 60 and 90. Downregulation of 
Noggin corresponded to limited bone formation at the periphery of the device at day 90. In 
the TGF-β3 loaded 7% HA/CC constructs there was significant downregulation of BMP-2 
expression on day 15, followed by upregulation on day 60 and 90. BMP-2 upregulation 
was accompanied by the concomitant upregulation of RUNX-2 and Osteocalcin, along with 
prominent induction of bone formation. These results unequivocally show that in the rectus 
abdominis muscle of Papio ursinus TGF-β3 induces bone formation by upregulating BMP 
expression via Noggin transcription, together with controlling the differentiation of a 
progenitor stem cell niche to enhance osteoblastic cell differentiation and proliferation.  
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 2 
PREFACE 
The biological activities of the soluble molecular signals of the transforming growth factor-
β (TGF-β) supergene family are inexorably linked to biomaterial sciences (Reddi, 1994). 
The connubium of a soluble and an insoluble signal is epitomized by the biological 
evidence that when implanted in heterotopic extraskeletal sites of animal models singly 
they lack the capacity of initiating the induction of bone formation (Sampath and Reddi 
1981). The soluble signal needs to be reconstituted or recombined with an insoluble signal 
or substratum to trigger the ripple-like cascade of bone formation by induction (Sampath 
and Reddi 1981; Sampath and Reddi 1983). Thus the greatest challenges of bone tissue 
engineering have been, on the one hand, to understand how topographical surface 
modifications of the insoluble signals or substratum set into motion the molecular and 
cellular cascade leading to tissue induction and morphogenesis (Fu et al. 2010; Chou et al. 
1995; Curran et al. 2006; Vlacic-Zischke et al. 2011; Gittens et al. 2011; Wilkinson et al. 
2011; McNamara et al.; 2011; Ripamonti et al. 2012), and on the other hand, to define the 
initiating soluble signals that start bone formation (Ripamonti et al. 1997; Ripamonti et 
al.2004; Ripamonti et al.2008; Ripamonti and Roden 2010).  
The insights of Urist (1965), Reddi and Huggins (1972), Sampath and Reddi (1981; 
Sampath and Reddi 1983), Wozney et al. (1988), Celeste et al. (1990), Özkaynak et al. 
(1990) permitted the isolation, characterisation and molecular cloning of an entirely new 
family of protein initiators collectively called bone morphogenetic/osteogenic proteins 
(BMPs/OPs), members of the TGF-β supergene family (Wozney et al. 1988; Ripamonti et 
al. 2004; Ripamonti 2006). BMPs/OPs when implanted in heterotopic extraskeletal sites of 
animal models including non-human primates induce the formation of new bone (Reddi  
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1994; Reddi 2000; Ripamonti 2004; Ripamonti 2006). The substantial induction of bone 
formation in pre-clinical animal studies prematurely convinced basic scientists and skeletal 
reconstructioneers that an application of a single dose of a recombinant human bone 
morphogenetic protein would induce tissue morphogenesis, in a clinical environment 
(Friedlaender et al. 2001; Govender et al. 2002). However, this theoretical potential has so 
far not been successfully translated to clinical context. Clinical trials of craniofacial 
orthopaedic applications such as mandibular reconstruction have indicated that supra 
physiological doses of a single recombinant human BMPs/OPs (hBMPs/OPs) are needed 
to often induce clinically unacceptable induction of bone, which still falls short of 
autogenous bone grafts (Ripamonti et al. 2006; Ripamonti et al. 2007; Ripamonti 2009; 
Garrison et al. 2007; Mussano et al. 2007). Because of the often substandard regeneration 
of osseous defects in humans implanted with hBMPs/OPs, this thesis now finally asks the 
prevocative question: are the BMPs/OPs the only initiators of the induction of bone 
formation?  
Implantation of coral-derived calcium carbonate-based macroporous constructs alone or 
combined with recombinant human TGF-β3 (rhTGF-β3) induces bone formation in 
heterotopic intramuscular sites of the non-human primate Papio ursinus (Papio ursinus) 
(Ripamonti 1990; Ripamonti 1991; Ripamonti et al. 2008; Ripamonti et al. 2012). Taken 
in context of how gene expression, the algorithm formula for all biological life (Mendel, 
1886), affects and directs cellular form and function, the present thesis sought to define 
some of the mechanisms by which coral-derived macroporous constructs and hTGF-β3 
induce bone formation in heterotopic sites of Papio ursinus.  
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CHAPTER 1: Introduction with Literature Review 
1. Introduction 
A great unsolved challenge in regenerative medicine and tissue engineering is to restore 
craniofacial and appendicular bony defects brought about by genetic mutations, 
pathologies or trauma (Ripamonti et al. 1997). Substantial research has been committed 
towards understanding what it is that confers to the skeleton its remarkable repair potential, 
which as been observed since Hippocratic times (quoted by Reddi 1994; Reddi 2000). 
What are the molecular and cellular signals that are set into motion to induce the cascade 
of bone differentiation? This Introduction with associated Literature Review provides an 
overview of the signals and mechanisms that initiate and maintain the fascinating scenario 
of “Bone: formation by autoinduction” (Urist 1965; Reddi and Huggins 1972). 
 
1.1 Osteogenesis 
Osteogenesis is the process by which new bone is formed. There are two ways by which 
bone is formed. The aggregation and conversion of mesenchymal cells into osteoblasts 
laying down newly formed bone is defined as intramembraneous ossification (Gilbert 
2000). The craniofacial bones are formed by intramembraneous ossification. Endochondral 
ossification is the process whereby the appendicular skeleton is formed and it involves the 
formation of a cartilage anlage that forms the cellular strut for vascular invasion, 
chondrolysis, bone marrow formation and osteoblastic-like cell differentiation with 
synthesis of bone matrix (Gilbert 2000). 
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 Intramembraneous ossification 
Neural crest-derived mesenchymal cells proliferate and form dense condensations of 
aggregated mesenchymal cells (Gilbert 2000) where new bone is to be formed later by 
differentiating osteoblasts. Whilst a constituent of these condensed cells are utilised for 
capillary formation, the greater majority transform into osteoblasts, the precursor cells 
required for the successful deposition of new bone matrix (Fig. 1).  
The osteoblasts secrete a collagen-proteoglycan matrix (osteoid) that has a high binding 
affinity for calcium salts (Gilbert 2000). When calcium salts associate with the osteoid it 
becomes mineralized. The osteoblasts then are separated from the region of mineralization 
by a layer of osteoid matrix, i.e. newly deposited as yet to be mineralized bone matrix 
(Gilbert 2000). Osteoblasts are then later entrapped within the newly formed and 
mineralized matrix as osteocytes.    
 
 
 
 
 
 
 
Figure 1. Diagram of 
intramembraneous ossification. 
Mesenchymal cells condense and 
transform into osteoblasts, which 
deposit osteoid. Osteoid matrix 
becomes calcified resulting in bone.  
(Adapted from Gilbert 2000) 
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 Endochondral ossification 
Endochondral ossification is characterised by a cartilage anlage that provides the strut for 
tissue induction, angiogenesis and vascular invasion followed by chondrolysis and 
osteoblastic cell differentiation (Horton 1990; Gilbert 2000).  
Mesenchymal cells differentiate into cartilage cells, i.e. chondroblasts which express 
cartilage associated genes (Cserjesi et al. 1995; Sosic et al. 1997). Later chondroblasts 
condense into compact nodules and complete their transition into chondrocytes (Gilbert 
2000). As chondrocytes differentiate they undergo mitosis rapidly. The third stage of 
endochondral bone formation is characterised by rapidly proliferating chondrocytes that 
assemble themselves in a cartilage anlage of a model where bone will form. Once properly 
arranged within this pre-structure bone model, chondrocytes enter a quiescent phase. 
Chondrocytes increase in size and volume effectively becoming hyper chondrocytes 
(Gilbert 2000). Hyperthrophic chondrocytes deposite further cartilaginous matrix notably 
with abundant fibronectin and type X collagen and additionally secrete small membrane-
bound vesicles into the extracellular matrix. These vesicles contain enzymes that set into 
motion the mineralization process within the cartilaginous matrix (Wu et al. 1997). The 
induction of bone formation is brought about by angiogenesis and vascular invasion of the 
cartilage. Vascular invasion is followed by apoptosis of the hyperthrophic chondrocytes or 
chondrolysis, that is the lysis of newly formed mineralized cartilage later to become the 
newly formed marrow spaces sourronded by newly formed bone (Hatori et al. 1995; 
Rajpurokit et al. 1999). Cells surrounding the dying hypertrophic chondrocytes 
differentiate into osteoblasts and form new bone on the degrading cartilaginous   
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matrix (Bruder and Caplan 1989; Hatori et al. 1995). 
These two processes of osteogenesis occur primarily during embryogenesis within 
vertebrates (Gilbert 2000). However bone formation is not a singular event as over the 
course of a vertebrate‟s life, bone is constantly being re-formed by resorption and 
remodelling (Reddi 1994; Reddi 1997; Gilbert 2000). These events have been shown to be 
crucial for maintaining the bones structural integrity, as well as repairing the bone should it 
be damaged (Reddi 1997; Gilbert 2000). 
 
1.2 Bone remodelling  
The remodelling of bone, as reported by Eriksen (1986), is a continuous process which 
occurs during specific stages of foetal life and continues once the skeleton has fully formed 
in vertebrates. The bone remodelling cycle is categorised by a series of crticial and step by 
step molecular and cellular events (Eriksen 1986; Parfitt 1994). During remodelling, two 
cell lineages are critical - the mesenchymal osteoblastic and the hematopoietic osteoclastic 
lineages (Raisz 1999). Resorption and formation exist within a balanced homeostatic 
equilibrium (Frost 1990). Old bone is continuously replaced by newly formed bone as the 
bone adapts to mechanical loads and strains (Frost 1990). Several studies have indicated 
that bone remodelling is controlled by several molecular, ionic and cellular mechanisms 
ultimatly controlling bone resorption coupled with bone deposition (Boyce et al. 2012; 
Boyle et al. 2003; Caudarella et al. 2011; Hwang and Putney 2011; Hadjidakis and 
Androulakis 2006).  
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Osteoclasts and osteoblasts are known to cooperate closely with each other in the 
remodelling process in what is called a basic multicellular unit (BMU) (Hadjidakis and 
Androulakis 2006). The BMUs are organized differently throughout cortical and trabecular 
bone, the latter housing the bone marrow. Within the cortical bone the BMU has been 
shown to cut, at an estimated rate of 20 μm per day, a cylindrical canal, approximately 
2,000 μm in length and 150–200 μm in width, within the mineralized bone (Petryl, 1996). 
It has thus been suggested that during 24 hours, ~10 osteoclasts excavate a circular tunnel 
in the dominant loading direction (Petryl 1996), which is filled in with new bone via 
several thousands of osteoblasts (Parfitt 1994). Thus per annum about 2- 5% of cortical 
bone is being remodelled in this way. In contrast to this, trabecular bone is more actively 
remodelled than cortical bone. Trabecular bone surface to volume ratio has been shown to 
be much greater (Hadjidakis and Androulakis 2006). Time loop experimentation indicated 
that osteoclasts move across the trabecular bone surface at speeds of up to 25 μm per day, 
excavating trenches at an approximate depth of 55 μm (Hadjidakis and Androulakis 2006) 
allowing bone remodelling to occur efficiently and effectively within a relative small 
amount of time. 
The remodelling cycle (Fig. 2) has been shown to consist of three consecutive phases: 
resorption, reversal and formation (Gilbert 2000; Parfitt 1994; Hadjidakis and Androulakis 
2006). The induction of bone formation relies on these three phases to be initiated and 
though several molecular signals have been linked to the remodelling cycle, it is yet still 
unclear which are the specific signals and/or signal that initiate the remodelling cycle. The 
present doctoral thesis attempted to study in vivo the control of the remodelling cycle by 
inhibiting osteoclastic activity, essential for bone formation to occur.   
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The first stage of the remodelling cycle or quiescent phase is morphologically 
characterized by trabeculae of bone lined by flattened mesenchymal cells not as yet 
activated but rather in a quiescent state (Parfitt 1994). Mononuclear pre-osteoclasts migrate 
to the surface of the bone as directed there either by calcium ion release (Boyce et al. 2012; 
Boyle et al. 2003; Caudarella et al. 2011; Hwang and Putney 2011) or soluble signals 
secreted by either osteocytes, osteoblasts and/or endothelial cells (Hadjidakis and 
Androulakis 2006) or possibly even by just the activated quiescent lining cells. Pre-
osteoclasts undergo their transition into multinucleated giant cells and attach to the 
mineralized bone surface. Testing of pH revealed that an acidic pH is created in the zone of 
resorption created by osteoclasts (Vaananen et al. 2000). Osteoclasts secrete hydrogen ions 
together with lysosomal enzymes, primarily Cathepsin K, and eventually dissolve the 
mineralized component of the bone matrix (Vaananen et al. 2000). The resorption process 
by osteoclasts produces irregular scalloped concavities of various dimensions , radii and/or 
curvatures on the bone surface, which are referred to as Howship lacunae, or cylindrical 
Haversian canals in the cortical bone (Gilbert 2000; Hadjidakis and Androulakis 2006). 
After the completion of osteoclastic resorption, the reversal phase is entered (Parfitt, 1994).  
Mononuclear cells appear on the bone surface (Parfitt 1994). These cells prime the surface 
by promoting further degradation of the bone collagenous matrix, depositing proteoglycans 
to form a so-called cement line and release specific growth factors, which then initiate the 
formation/deposition phase of new bone at the site of the osteoclastic cut concavities 
(Parfitt 1994).   
In the final formation phase, the differentiated osteoblasts, which have differentiated from  
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mesenchymal precursors, then deposit new bone matrix until the resorbed area within the 
bone is completely replaced by new osteogenic material (Parfitt 1994; Gilbert 2000; 
Hadjidakis and Androulakis 2006). Once this stage has been completed the surface of the 
site of new bone within pre-existing bone is covered once again by flattened lining cells 
and a prolonged quiescent phase begins until the remodelling cycle is re-initiated (Parfitt 
1994; Gilbert 2000). 
The remodelling cycle of the osteonic cortical bone with the three continuous phases of 
resorption, reversal and formation may possibly relate to the often extraordinary repair 
capacity of the bone matrix and of the skeleton in several animal models including 
humans. This remarkable potential to heal without scarring has fascinated scientists for 
centuries and has led to the development of a continuous effort to mechanistically 
understand the capacity of bone repair and the induction of bone formation which would 
become known as the “bone induction principle” (Urist et al. 1967; Urist et al.1968). 
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1.3 Bone: formation by autoinduction – a basic historical perspective 
The history of regenerative medicine and bone tissue engineering has been shaped from the 
pioneering scientific work of several scientists across the world, which firstly developed 
and later set the basic principles of bone tissue engineering. 
Senn (1889) was one of the first pioneers to investigate bone regeneration by implanting 
decalcified bone segments in skull defects of canines. Perceptively, Senn (1889) after 
having observed that the decalcified bone matrix was incorporated by a mass of embryonic  
Figure 2. The bone remodeling cycle. Flattened mesenchymal cells line the surface of the bone 
(1). Pre-osteoclasts migrate to the surface of the bone and differentiate into osteoclasts that resorb 
an area of bone, producing concavities (2). Monocytes then prime the surface of the newly cut 
concavities (3), which permits mesenchymal derived osteoblasts to deposit new osteoid within the 
cut area, which is then converted to new bone (4). A prolonged quiescence phase is then 
entered (5) before the next remodeling cycle begins (Adapted from Parfitt 1994).  
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tissue, stated that this was a necessary condition required for the proper formation of new 
bone at the site of the implantation (Senn 1889). The concept that postnatal bone formation 
after implantation of devitalized bone matrices develops by recapitulating embryonic 
developmental processes was possibly first alluded to by Senn (1889). 
Important contributions where brought about by Trueta (1963) who, through in depth 
morphological analyses, established that angiogenesis is a prerequisite for osteogenesis. 
However, the pioneering work of Levander (1938) provided important discoveries as well 
as terminology from which the bone induction principle would further develop. Levander 
(1938) used the term “tissue induction” upon implantation of bone matrices.  Levander 
(1938) showed that bone formation could be “induced” within heterotopic intramuscular 
sites when implanting ethanol-treated partially extracted bone matrices. Levander (1938) 
suggested that heterotopic intramuscular formation of bone was induced by “some 
substance extracted by alcohol from the skeletal tissue, a substance having the power to 
activate the non-specific mesenchymal tissue into the formation of bone tissue, either 
directly or via the embryonic prenatal stage of bone, viz. cartilage” (Levander 1938; 
Levander and Willestaedt 1946). Levander (Levander 1938; Levander and Willestaedt 
1946) thus additionally identified that the induction of bone formation in postnatal life is a 
repeat of embryonic development.  
Later Lacroix (1945) would aptly name this hypothetical substance or substances as 
“osteogenins.” It was however the fundamental work of Urist (1965), who established, 
from the previously published experimental works of Senn, Levander and Lacroix, the so 
called “bone induction principle” ((Urist et al. 1967; Urist et al.1968; Reddi 2000;  
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Ripamonti 2006). Marshall Urist routinely established the use of demineralized bone 
matrices to induce the differentiation of bone (Urist 1965). The constant reproducible 
induction of bone formation by demineralized bone matrices resulted in his classic Science 
paper titled “Bone: formation by autoinduction” (Urist, 1965). Importantly however the 
classic papers of Urist on the “bone induction principle” (Urist 1965; Urist et al. 1967; 
Urist et al. 1968) were also the result of previous published experiments in particular by 
Senn (1889) and Levander (1938), the former implanting demineralized bone matrix 
blocks, the latter speculating on the induction phenomena brought about by some 
“unknown substance” within the bone matrix (for review see Ripamonti et al. 2006). A 
further seminal contribution was the introduction of the morphogenetic concept of a 
hypothetical bone morphogenetic protein complex that initiates the induction of bone 
morphogenesis within the bone matrix. Urist‟s studies on the induction of bone formation 
in a variety of animal models including humans but particularly in the selection of the term 
“bone morphogenetic protein” (Urist and Strates 1971) have been the cornerstone for the 
emergence of all the studies on the “bone induction principle” (Urist et al. 1967; Urist et 
al.1968; Reddi 2000; Ripamonti et al. 2006; Ripamonti 2006).  
Seminal work on the biochemical and morphological cascades of bone differentiation by 
induction followed shortly (Reddi and Huggins 1972; Reddi 1984) with partial purification 
(Sampath and Reddi 1981; Sampath and Reddi 1983) to apparent homogeneity  of the still 
“elusive” morphogenetic factors (Sampath et al. 1987; Luyten et al. 1989; Ripamonti et al. 
1992). 
Previous studies have shown that osteogenesis can be induced by ligation of the renal  
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arteries (Sacerdotti and Frattin 1901) or surgically lacerating the urinary bladder wall 
(Huggins 1931; Friedenstein 1968). Friedenstein (1968) asked how the induction 
“stimulus” is transferred from the transitional epithelium and other matrices, including 
demineralized bone matrices, to the surrounding responding cells. Friedenstein implied that 
there must be the presence of a “soluble inductor,” a signal that was responsible for the 
induction of bone formation (Friedenstein 1962). This query would become the foundation 
that would shape and later define the “bone induction principle” and the “osteogenic 
activity” of transplanted matrices, including dentine, uroepithelium and bone (for review 
Ripamonti et al. 2006).   
As per Urist hypothesis (Urist and Strates 1971), a bone morphogenetic protein complex 
within demineralized bone and dentine matrices would provide reproducible evidence of 
bone formation by induction upon implantation in heterotopic sites. The identification of 
this elusive bone morphogenetic protein complex was problematic however, since the 
extracellular matrix of bone “exists in a solid state” (Reddi 1997), with the resident 
morphogenetic proteins tightly bound to the inorganic and organic components of the bone 
matrix (Sampath and Reddi 1984). 
Sampath and Reddi (1981) bypassed “the bone matrix in the solid state” (Reddi 1997) by 
successfully dissociatively extracting the bone matrix using chaotropic agents such as 
guanidinum and/or urea hydrochloride. This resulted in the preparation of an insoluble 
inactive collagenous residue and soluble signals, the “putative” extracted osteogenic 
proteins (Sampath and Reddi 1981; Sampath and Reddi 1983). Separately neither of the 
two phases, i.e. the extracted solubilised proteins nor the insoluble collagenous bone  
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matrix (ICBM), induced bone formation when implanted subcutaneously in rodents 
(Sampath and Reddi 1981). The osteogenic activity of the intact demineralized bone matrix 
disappeared when it was separated by chaotropic extraction (Sampath and Reddi 1981). 
Only when the two components separated by chaotropic extraction, i.e. the molecular 
signals in a soluble state were recombined or reconstituted with the insoluble signal of the 
ICBM was the inductive potential restored (Sampath and Reddi 1981). The discovery that 
bone matrix could be dissociatively extracted yielding soluble morphogenetic signals that 
when reconstituted with the inactive residue restored the osteogenic activity of the intact 
demineralized bone matrix, showed that the extracellular matrix of bone is a reservoir for 
soluble morphogenetic signals that initiate the cascade of bone formation by induction 
(Sampath and Reddi 1981; Sampath and Reddi 1983; Ripamonti and Reddi 1995; Reddi, 
2000).  
Additionally, the chaotropic dissociative extraction provided a bioassay by which proteins 
could be identified and classified in vivo for its osteoinductive potential (Sampath and 
Reddi 1983). Bone formation is only induced when a soluble signal is recombined with an 
insoluble signal or substratum implanted in heterotopic extraskeletal sites in vivo (Sampath 
and Reddi 1981; Sampath and Reddi 1983; Reddi 2000).  
The operational reconstitution of a soluble morphogenetic signal with an insoluble signal 
or substratum is now known as the “bone tissue engineering paradigm” (Sampath and 
Reddi 1981; 1983; Khouri et al. 1991; Ripamonti and Reddi 1995; Reddi 2000). Of note 
however, homologous xenogeneic proteins recombined with recipient allogeneic insoluble 
collagenous matrix could also induce bone formation (Sampath and Reddi 1983;    
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Ripamonti and Reddi 1995) but not vice versa. This implied that bone inductive signals 
share important homologies across mammalian species whereas the insoluble collagenous 
bone matrix retains the antigenic load across species (Sampath and Reddi 1983; Ripamonti 
and Reddi 1995). 
After the realization that the hypothised morphogenetic proteins were tightly bound to the 
bone matrix and could be dissociatively extracted from bone matrix (Sampath and Reddi 
1981; Sampath and Reddi1983), the soluble signals were eventually identified, purified 
and isolated, yielding an entirely new family of protein initiators collectively called the 
bone morphogenetic/osteogenic proteins (BMPs/OPs) (Wang et al. 1988; Wozney et al. 
1988). BMPs/OPs were determined to belong to the transforming growth factor-β (TGF-β) 
supergene family (Wozney et al. 1988; Özkaynak et al. 1990; Reddi 2000; Ripamonti et al.  
2004; Ripamonti 2006). The molecular cloning of the now available recombinant human 
BMPs/OPs has resulted in extensive testing in vitro and in vivo including pre-clinical 
experimentation in non-human primates (Ripamonti et al. 2001; Ripamonti 2006). This has 
culminated in the use of recombinant human OP-1 (hOP-1) and hBMP-2 in clinical context 
(Reddi 2000; Ripamonti et al. 2000; Ripamonti et al. 2001; Ripamonti et al. 2007; 
Friedlaender et al. 2001; Govender et al. 2002; Ripamonti, 2006; Ripamonti 2010) 
 
1.4 Induction of bone formation by coral-derived macroporous biomimetic matrices 
The understanding of the fascinating phenomenon of “Bone: formation by autoinduction” 
(Urist 1965; Reddi and Huggins 1972) has been vital for the construction of the biological  
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algorithms in inductive tissue engineering. To successfully induce tissue formation a 
soluble recombinant molecular signal must be combined with an insoluble substratum, 
which then activates the morphogenetic and tissue inductive processes (Reddi 1994; 
Ripamonti et al. 2004; Ripamonti 2006; Ripamonti et al. 2006; Reddi 2000; Ripamonti 
2004a). Additional requirements to obtain successful morphogenesis, as established by 
Reddi (2000), were the extracellular matrix, responding stem cells and inductive soluble 
signals. The extracellular matrix is the macro-environment, and can be functionally 
duplicated by the supra-molecular assembly of new biomimetic matrices (Reddi 2000; 
Ripamonti et al. 2007a; Ripamonti 2009).  In order to induce the morphogenesis of 
specialised organs and tissues, without the need to rely on a multitude of highly diverse 
proteomic regulators, Nature has come up with simple solution. By adjusting the protein 
structure, through minor variations in the amino-acid structure within highly conserved 
carboxy-terminal regions, a single protein family can perform multiple functions. The 
transforming growth factor-β (TGF-β) supergene family is a classical example of 
pleotropic activity (Ripamonti 2006; Ripamonti et al. 2006; Ripamonti et al. 2007a). 
The theory for the best possible induction of bone formation relies on the joint action of a 
complementary substratum together with a soluble osteogenic molecular signal is of 
pivotal importance for the development of future therapeutic strategies (Ripamonti and 
Reddi 1995; Ripamonti and Duneas 1996; Ripamonti and Duneas 1998; Reddi 2000). 
Indeed, biomimetic matrices that imitate or replicate biological structures in mammals 
have been shown to initiate the induction of bone formation even in the absence of 
exogenously applies BMPs/OPs (Ripamonti 1990; Ripamonti 2009). 
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Replication of the remodelling process and subsequent bone formation can be achieved by 
biomimetic matrices which are constructed with cyclical concavities, e.g. biphasic or 
highly crystalline hydroxyapatite/β-tricalcium phosphate, as they possess the geometric 
configuration that set into motion the induction of bone formation (Ripamonti et al. 2007a; 
Ripamonti et al. 2008; Ripamonti et al. 2009; Ripamonti 2004a; Ripamonti 2009). 
Research in Papio ursinus has shown that the biomimetism of extracellular matrix directs 
the function of the designed molecular biomimetic matrices (Ripamonti et al. 2007; 
Ripamonti et al. 2009; Ripamonti 2004; Ripamonti 2009). The geometric blueprint of the 
biomaterial influences the inductive potential of the molecular osteogenic signals to initiate 
the induction of bone formation (Ripamonti 2004). “The language of shape is the language 
of geometry, and the language of geometry is a sequence of repetitive concavities cut 
within biomimetic matrices that biomimetize the remodeling cycle of osteonic bone in 
primates” (Ripamonti 2004; Ripamonti 2009) 
A very interesting occurrence is the “spontaneous” induction of bone formation when 
utilizing a variety of porous biomimetic matrices (Ripamonti 2004; Ripamonti 2006: 
Habibovic et al. 2006). Selye et al. (1960) was the first to report on the induction of bone, 
cartilage and hematopoietic tissue formation in rodents. Later Winter and Simpson (1996) 
showed that porous poly-hydroxethyl-methacrylate implanted within heterotopic sites of 
Large White pigs could also induce bone formation. However it would be the systematic 
studies of Ripamonti (1990; Ripamonti 1991; Ripamonti et al 1993; Ripamonti et al. 1996; 
Ripamonti et al. 2009) that showed that calcium phosphate based bioreactors, implanted  
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within the heterotopic sites of the non-human primate Papio ursinus could spontaneously 
and reproducibly induce new bone formation. The morphogenesis of bone following 
heterotopic implantation of coral-derived macroporous constructs has been instrumental 
for the development of highly sintered crystalline hydroxyapatite with a series of self-
inducing repetitive concavities (Ripamonti et al. 1999), culminating in the construction of 
„smart’ biphasic/ tri-calcium phosphate macroporous constructs inducing significant 
amount of bone formation in both heterotopic and orthotopic sites of Papio ursinus 
(Ripamonti et al. 2008).    
Coral-derived macroporous constructs have yielded important information on the induction 
of bone formation and on the induction of the osteogenic phenotype when implanted 
heterotopically in the rectus abdominis muscle of the non-human primate Papio ursinus 
(Ripamonti 1990; Ripamonti 1991; Ripamonti et al. 1993; Ripamonti 1996: Ripamonti 
2009; Ripamonti et al. 2009). Time studies in vivo have suggested that myoblastic and/or 
pericytic stem cells attach to the surface of the macroporous construct, differentiating and 
proliferating into osteoblastic-like cells (Ripamonti et al. 1993; Ripamonti et al. 2009). 
Morphological analyses have shown a continuous stream of stem cells migrating from the 
vascular compartment towards the osteoblastic compartment attached to the implanted 
substratum (Ripamonti et al. 1993). 
Immunohistochemical staining of the implanted macroporous constructs have further 
shown the presence of alkaline phosphatase and laminin expression within the invading 
capillaries that sprout within the macroporous spaces (Ripamonti et al. 1993). Collagenous 
condensations that form within the macroporous spaces and undergoing mineralization  
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together, with the differentiation of osteoblastic-like cells and deposition of osteoid matrix 
have also been observed (Ripamonti et al. 1993).  The differentiation of mesenchymal 
collagenous condensations at the interface of the hydroxyapatite has been suggested to be a 
prominent differentiating event predating the induction of bone formation within coral-
derived macroporous constructs (Ripamonti 1990; Ripamonti 1991; Ripamonti 2009; 
Ripamonti et al. 1993). 
Since then, coral-derived macroporous constructs, highly sintered crystalline 
hydroxyapatites and biphasic hydroxyapatite/β-tricalcium phosphate have been shown to 
“spontaneously” induce bone formation when implanted in the rectus abdominis muscle of 
Papio ursinus, and without any exogenous applications of osteogenic molecular signals 
(Ripamonti 1990; Ripamonti 1991; Ripamonti et al. 1993; Ripamonti et al 1999; 
Ripamonti et al 2001; Ripamonti et al 2004; Ripamonti et al 2011; van Eeden and 
Ripamonti 1994; Ripamonti 1996; Ripamonti 2000; Ripamonti 2004a; Ripamonti 2006; 
Ripamonti 2009; Magan and Ripamonti 1996; Ripamonti and Roden 2010). 
To summarise, the basic principle of bone formation by induction is to combine an 
insoluble substrata with a soluble osteogenic molecular signal that through their union 
form a support that resembles the original shape and function of in vivo bone (Sampath 
and Reddi 1981; Khouri et al. 1991; Reddi 1994; Reddi 2000; Ripamonti et al. 1993; 
Ripamonti 2006). However, the above paradigm has since then been modified in which it 
is proposed that the initiation of bone formation within heterotopic extraskeletal sites can 
be induced by biometic biomaterial matrices without the exogenously applied soluble 
osteogenic molecular signal (Ripamonti 2004; Ripamonti 2006).  
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Hence, how then do coral-derived calcium phosphate-based macroporous constructs 
initiate the induction of bone formation? This was the first important question the present 
doctoral study sought to answer.   
 
1.5 Bone formation by TGF-β superfamily members 
The incisive work of Wozney et al. (1988) finally permitted the molecular cloning of 
several BMPs/OPs, which were found to be members of the TGF-β supergene family. 
Proteins were firstly isolated after increasingly chromatographic purification methods 
(Urist et al. 1984; Sampath et al. 1987; Luyten et al. 1989; Wang et al. 1988; Ripamonti et 
al. 1992). Amino acid sequence motifs of batches of purified proteins were then used for 
molecular cloning of an entirely new family of proteins initiators, collectively called the 
BMPs/OPs (Wozney et al. 1988; Celeste et al. 1990; Özkaynak et al. 1990; Hammonds et 
al. 1991; Sampath et al. 1992). We have since then learned that BMPs/OPs are a family of 
highly conserved secreted pleitropic proteins that intiate cartilage and bone formation in 
vivo (Wosney et al. 1988; Sampath et al. 1992; Reddi 200; Ripamonti 2006; Ripamonti et 
al. 2004).  
BMPs/OPs have also been shown to be involved in pattern formation during embryonic 
organogenesis (Reddi 2005). A remarkable characteristic of BMPs/OPs gene products is 
that when implanted heterotopically extraskeletally in animal models they induce de novo 
endochondral bone formation (Reddi 2000; Ripamonti et al. 2004; Ripamonti 2006).  
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 The BMPs/OPs and their signal transduction pathway  
Development, embryogenesis, pattern formation and organo-and skeletogenesis require the 
action of BMPs (Alliston et al. 2008). BMP signalling is regulated via their localised 
expression, the action of specific antagonists and a series of negative and positive feedback 
loops (Alliston et al. 2008) (Fig. 3). During skeletal development BMPs-2 - 7 have an 
overlapping pattern of expression to ensure development occurs in an ordered manner 
(Solloway et al. 1998). Whilst BMP receptors type II and type I alpha (BMPRII and 
BMPRIA), like most members of the TGF-β family,  are ubiquitously expressed 
(Kawabata et al. 1995), BMPR type I beta (BMPRIB), as shown by Ishidou et al. (1995), 
they are principally transcribed only within developing bone and cartilage. Only when 
bone, in adult life, is damaged are all BMP receptors expressed (Onishi et al. 1998), as 
they facilitate the activation of the bone regeneration cycle. Subsequently, further research 
studies by Rickard et al. (1998), Mundy et al. (1999) and Rawadi et al. (2003) have shown 
that additional proteins, specifically statins, estrogen and wingless-type MMTV integration 
site family member 3A (Wnt3a), are also capable of activating the BMPs.   
The activities of the BMPs are highly regulated by a series of antagonists and agonists.  
Chordin, Follistatin, Gremlin, Noggin and Sclerostin are specific antagonists known to 
inhibit the BMP pathway activation and thus bone formation (Alliston et al. 2008). 
Research studies have revealed BMPs are also capable of activating the expression of their 
inhibitors including Noggin and the intracellular BMP pathway inhibitory Smad family 
members 6 and 7 (Smad6 and Smad7) (Fig.3) (Gazerro et al. 1998; Takase et al. 1998; 
Ishiskai et al. 1999; Pereira et al. 2000; van Bezoojien et al. 2005). Additionally, members 
 24 
CHAPTER 1: Introduction and Literature Review 
of the entire BMP signalling pathway, including their initiators and antagonist are 
subjected to further regulation by a series of positive and negative feedback signalling 
loops that interact with other signalling pathways (Alliston et al. 2008).  
BMP signalling commences when a BMP ligand binds first to either the BMPR1A or 
BMPRIB, after which it forms a receptor complex with BMPRII, i.e. BMPRIA/B + 
BMPRII (Berk et al. 1997; Hayashi et al. 1997; Imamura et al. 1997; Yoshida et al. 2000; 
Sowa et al. 2004). This active complex then activates the Smad transcription receptor 
complex to regulate nuclear transcription factor activity (Berk et al. 1997; Hayashi et al. 
1997; Imamura et al. 1997; Nakao et al. 1997; Yoshida et al. 2000; Sowa et al. 2004). It is 
this spatial and temporal regulation of the various components of the BMP pathway that 
ensure proper skeleto-and organogenesis during embryo development as well as the 
maintenance of bone later in postnatal life (Alliston et al. 2008). 
Storm et al. (1994) revealed that Growth differentiation factor (GDF)-5, -6 and -7, also 
referred to as cartilage-derived morphogenetic proteins (CDMP-1, -2, and -3) (Chang et al. 
1994; Storm et al. 1994) are involved in bone formation and development in vivo (Mikic et 
al. 2002). GDF-5 to -7 have been found, via gene knocked studies, to control the length of 
long bone formation in limbs and regulate patterning of segments in the digits, 
chondrogenesis and longitudinal bone growth (Storm et al. 1994; Storm and Kingsley 
1996; Storm and Kingsley 1999). GDFs have also been shown to induce osteogenic 
differentiation within in vitro stem cell differentiation studies (Erlacher et al. 1998; Yeh et 
al. 2005). 
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 The TGF-β isoforms and signal transduction pathway 
The three mammalian TGF-β isoforms, TGF-β1, TGF-β2 and TGF-β3 have been shown to 
signal through receptor complexes of the TGF-β type II receptor (TßRII) and TßRI 
(Alliston et al. 2008) (Fig. 4). In vitro research has shown that all three of TGF-β isoforms 
function similarly at the cellular level (Alliston et al. 2008) but differently throughout 
embryonic osteogenesis (Alliston et al. 2008). In knockout studies during murine 
development each corresponding gene produced unique phenotypic deviations, which 
reflect their different spatio-temporal distributions and roles. Knock-out studies of TGF-β1 
resulted in abnormal bone quality (Shull et al. 1992; Kulkarni et al. 1993), whereas 
deletions of TGF-β2 or TGF-β3 impaired epithelial-mesenchymal transdifferentiation, cyto-
proliferation and palate formation of the skull (Kaartinen et al. 1995; Proetzel et al. 1995; 
Sanford et al. 1997). 
During bone formation in skeletogenesis the expression patterns of the various TGF-β 
isoforms are further modulated by a series of positive and negative feedback loops 
(Alliston et al. 2008). However, there are apparent differences between the mRNA and 
protein expression patterns, which regulate TGF-β isoform storage in cartilage and bone 
(Alliston and Derynck 2000). Pelton et al. (1991) found that extracellular matrix proteins 
from bone interact with certain of TGF-β isoforms, particularly TGF-β1, to allow for them 
to be stored within bone. In the mesenchyme, all TGF-β isoforms are expressed and during 
condensation of the mesenchyme their expression increases (Alliston et al. 2008). 
Experimental research has revealed that TGF-β3 is expressed at high levels during the early 
development of cartilage formation, whereas TGF-β1 and TGF-β2 expression is very low 
 27 
Chapter 1: Introduction with Literature Review 
 (Pelton et al. 1990; Pelton 1991). As bone development progresses, TGF-β3 levels 
diminish and TGF-β1 and TGF-β2 levels increase (Pelton et al. 1990). Primarily it seems 
that TGF-β3 levels are highest in tissues associated with skeletogenesis and bone 
formation, whereas TGF-β2 is highly transcribed in areas of new bone mineralization 
(Alliston et al. 2008). 
In previous research studies of mouse cartilage, TGF-β3 expression is higher than in 
relation to the other TGF-β isoforms (Pelton et al. 1990; Pelton 1991). Subsequently other 
research studies on the mouse growth plate have found that whilst TGF-β2 is transcribed 
throughout all the regions of the developing plate, whereas TGF-β1 and TGF-β3 are 
restricted to only the hypertrophic and proliferative areas (Sandberg et al. 1988; Millian et 
al. 1991; Thorp et al. 1992; Horner et al. 1998). The periosteums of endochondral and 
intramembraneous bones show high levels of expression of TGF-β1 and TGF-β2 
respectively, whilst osteoclasts and osteoblast show varied expression patterns in TGF-β 
isoforms (Pelton et al.(1991)..  
In developing bones the TβRI and TβRII are transcribed throughout the developing 
embryonic skeleton (Horner et al. 1998), but in hypertrophic chondrocytes and mineralized 
osteophyte tissue their expression is reduced and lost, respectively (Horner et al. 1998). 
The Smads, known regulators of the TGF-β pathway, are also subject to regulation in 
skeletal tissue (Sakou et al. 1999). In vitro cell culture experiments have shown that 
Smad2, Smad3 and Smad4 including the inhibitory Smads, Smad6 and 7 are all 
differentially expressed within proliferating chondrocytes and bone cells (Sakou et al. 
1999; Alliston et al. 2008).  
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Inactivation and storage of TGF-β isoforms has been shown to be facilitated by latent 
TGF-β-binding proteins (LTBPs) (Shipley et al. 2000). Among the four isoforms of 
LTBPs-(1-4), all but LTBP-2 have been shown to bind to the TGF-β isoforms (Shipley et 
al. 2000). Although all four LTBPs are broadly expressed and regulated, LPBT-3 
expression as shown by Shipley et al. (2000) is the highest in bone with LTBP-2 primarily 
expressed in chondrogenic condensations (Shipley et al. 2000). Although other studies 
have shown that there are ways in which the formation and storage of TGF-β complexes 
can be regulated (Kwok et al. 2005; Oreffo et al. 1989; Oursler 1994; Dallas et al. 2002), 
LTBPs are considered the primary mode during skeletal bone formation.  
The importance of BMPs and TGF-β isoform involvement in embryonic bone formation 
has been shown by various studies. However how BMPs and TGF-βs operate during the 
induction of bone formation is raising awareness especially with regards to which of these 
two pathways initiate and/or modulate the formation of bone by induction.  
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1.6 Molecular redundancy of the initiation of bone formation by induction 
 
We define the induction of bone formation as the de novo induction of endochondral bone 
when putative osteogenic proteins and/or biomimetic matrices are implanted 
heterotopically in different animal models. Recombinant hOP-1 induces bone 
differentiation in the non-human primate model Papio ursinus (Ripamonti et al. 2000a; 
Ripamonti 2005). Before 1993, the heterotopic bone formation could only be induced by 
BMP/OPs morphogens (Reddi 2000; Ripamonti et al. 2004; Ripamonti 2006). 
Homologues of the BMPs/OPs genes where subsequently identified and isolated from 
Drosophila melanogaster, i.e decapentaplegic (Dpp) and 60A genes (Sampath et al. 1993; 
Reddi 2000; Ripamonti 2006) revealing that BMPs/OPS are an ancient gene group that 
was important for the evolution of all vertebrate life  (Ripamonti 2006).  Indeed a research 
study conducted by Sampath et al. (1993) showed just how conserved these two 
gene/protein families were, when he successfully induced the formation of bone within 
heterotopic extraskeletal sites of rodents upon implantation of recombinant Dpp and 60A. 
This proved that embryonic patterning either in the fruit fly or vertebrates was linked, 
helping explain many aspects of embryonic development including hominid evolution 
(Ripamonti 2009). 
Some genes that are upregulated upon implantation of BMPs/OPs within heterotopic sites 
are OP-1, BMP-3, TGF-β1, and Type IV collagen, which as Ripamonti (2005) postulated 
are expressed during different developmental stages for different time intervals thus 
helping guide the formation of new bone formation by induction. 
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Though the induction of bone formation was previously only allocated to the BMPs/OPs, 
this categorization has since then become redundant since the three mammalian TGF-β 
isoforms, i.e. TGF-β1 TGF-β2 and TGF-β3, were shown to somehow induce new bone 
formation within heterotopic extraskeletal sites (Ripamonti et al. 1997; Ripamonti et al. 
2000; Ripamonti et al. 2008; Ripamonti et al. 2009 Ripamonti and Roden 2010). Whilst 
this function has still been restricted only to Papio ursinus, as previous experiments in the 
rodent and lagomorph models have failed to demonstrate the induction of bone formation 
by the three mammalian TGF-β isoforms (Roberts et al. 1986; Saadeh et al. 1999; Sampath 
et al. 1987; Hammonds et al. 1991; Shinozaki et al. 1997; Shah et al. 1995; Ripamonti et 
al. 2004), an important question has since been raised:  how do TGF-β isoforms induce 
bone formation? 
Though there are suggestions that the TGF-β isoforms may induce heterotopic bone 
differentiation by modulating the BMPs/OPs through their antagonist Noggin (Ripamonti 
and Roden 2010), this doctoral research sought to further define, more clearly, the bone 
inductive potential of TGF-β3, molecularly, so as to help pioneer the way for future 
therapeutical clinical applications.  
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2.1 Significance of Research 
This research sought to clarify which molecular signals, cellular mechanisms and /or genes 
initiate and regulate the bone induction cascade by coral-derived calcium carbonate/ 
hydroxyapatite-based macroporous constructs to expand the current paradigm of bone 
formation by autoinduction in the primate Papio ursinus.  
2.2 Aim and Objectives 
The aim of this study was to determine how coral-derived macroporous biomimetic 
matrices and hTGF-β3 induce bone formation when implanted in heterotopic intramuscular 
sites of the non-human primate Papio ursinus and was addressed by the following two 
objectives.  
Study Objective 1:  
To determine the role of osteoclastogenesis and calcium ions in the induction of bone 
formation by coral-derived macroporous constructs. 
Study Objective2:  
To determine how mammalian recombinant hTGF-β3 induces bone formation when 
combined to coral-derived macroporous constructs implanted within intramuscular 
sites of Papio ursinus.  
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6.1 A compositional standard for bone inductive biomaterials 
Coral-derived macroporous biomimetic matrices have emerged to be an effective 
biomaterial capable of autoinducing bone formation. Results of this study (Ripamonti et al. 
2010 (Chapter 3); Klar et al. 2013 (Chapter 4); Klar et al. 2014 (Chapter 5) have 
unraveled some of the cellular and molecular mechanisms underlying the induction of bone 
formation when macroporous bioreactors are implanted in heterotopic intramuscular sites 
of Papio ursinus.  
The intrinsic nature of the implanted biomatrices with its lacunae and concavities, which 
are further enhanced by osteoclastogenesis, in combination with Ca
2+
 release, are 
compelling morphogenic and ionic signals that promote the induction of bone formation 
(Klar et al. 2013). Residing stem cells are induced to differentiate along the osteoblastic 
lineage by Ca
2+
 release within the macroporous spaces after modification of the surface of 
the implanted device by osteoclasts (McNamara et al. 2010; Ripamonti et al. 2010; 
Wilkinson et al. 2011).  
As previous observations by Ripamonti et al. (Ripamonti 1990; Ripamonti 1991; 
Ripamonti et al. 1993; Ripamonti 2006) have shown, blood vessel and connective tissue 
formation and invasion occurs prior to the onset of bone formation. Prominent 
angiogenesis was supported in the present study by the observation that Collagen type IV 
was highly expressed at day 15 (Klar et al. 2013; Klar et al. 2014) in all samples. Type IV 
collagen is critical for the development of basement membrane in sprouting and invading 
capillaries (Reddi 2000). Once the foundation of collagenous condensation has been 
established, what follows is a systematic sequence of developmental processes triggered by  
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changes in the expression of key genes that promote the bone differentiation cascade, 
particularly the BMPs (Huang et al. 2010).  
As shown by Klar et al. (2013), important chemical and cellular cues are required to set 
into motion the induction of bone formation within the implanted coral-derived 
macroporous constructs. Klar et al. (2013) have demonstrated that osteoclastogenesis and 
Ca
2+
 plays an important role in establishing and maintaining the various signalling and 
expression pathways required to induce bone formation.  
Monocytes/macrophages differentiate into osteoclasts as they come in to contact with the 
Ca
2+
 which is released from the hydroxyapatite and calcium carbonate based biomimetic 
constructs when it is implanted in the acidic microenvironment of the surgical healing 
wound of the heterotopic intramuscular pouch (Kanatani et al. 1991, Müller et al. 2008). It 
is known that without topographical geometric alterations by the osteoclasts, in the shape 
of macro and micro-concavities, bone formation may be inhibited (Ripamonti et al. 1999; 
Ripamonti 2004; Ripamonti et al. 2009; Ripamonti et al. 2010). In addition osteoclasts also 
release Ca
2+
 (Teitelbaum, 2000), which then triggers a cascade of cellular events including 
osteoblastogenesis which deposits new bone matrix in the excavated concavities. However 
the present research also demonstrates that osteoclastogenesis exerts gene expression 
changes and indicates how subtle changes in this process can affect bone formation within 
the converted calcium carbonate derived devices (Klar et al. 2013). 
The loss in osteoclast binding due to zoledronate treatment of samples results in a 
temporary upregulation of Noggin at day 15 when compared to the untreated control 
samples and this corresponded morphologically to a delay in the formation of bone (Klar et  
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al. 2013). In addition to the upregulation of Noggin there is minimal expression of BMP-2.  
Noggin is known to prevent BMP binding to the BMP receptor (BMPR) (Zimmerman et 
al. 1996) and thereby inhibits bone formation by altering downstream signalling pathways.   
A possible mechanism for the observed upregulation of Noggin has been proposed based 
on the findings of Wei and Wan (2013) that have shown that osteoclasts display the 
peroxisome proliferator- activated gamma receptor (PPAγR). PPAγR is activated when 
osteoclasts bind to their respective surface material (Wei and Wan 2013) and prevents the 
activation of the downstream acting transcription factor β-catenin (Wei and Wan 2013). Β-
catenin is a known activator of Noggin expression (Domingos et al. 2001). Thus PPAγR 
activation through osteoclast binding would lead to the downregulation of Noggin. 
Inversely if PPAγR is not activated, because osteoclasts are prevented from binding, it 
would lead to β-catenin activation and hence increased Noggin expression. Indeed this 
deduction helps explains why in Klar et al. (2013) Noggin expression was increased. Lack 
of osteoclast binding produces an activation of β-catenin resulting in increased gene 
expression levels of Noggin and thus the inhibition of bone formation.  
When the L-type voltage gated ion channel for calcium was blocked by the preloading of 
the macroporous constructs with verapamil, bone formation within coral-derived devices 
was scant as observed by morphological and histomorphometric analysis (Klar et al. 2013). 
Whilst tissue patterning was not as disorganized or delayed as in the zometa-treated 
samples, at the molecular level there was the reduced expression in BMP-2 and the 
significant upregulation of Noggin at day 15. The qRT-PCR results show that in the 
absence of Ca
2+
, gene expression is greatly affected. In vitro studies performed by Bais et  
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al. (2009) supported these current findings. The alteration in gene expression profiles as a 
result of the Ca
2+
 modulation is a possible explanation why bone formation was so affected 
within coral-derived macroporous constructs pre-treated with Verapamil.  
There are a number of signal transduction pathways that affect bone formation by 
mediating cell differentiation into either osteoclast or osteoblasts (Fig. 1). 
Monocytes/macrophages are known to differentiate into osteoclasts when the receptor 
activator of nuclear factor-κB ligand (RANK-L) binds to the RANK receptor (Dougall et 
al. 1999; Ducy et al. 1997) ultimately resulting in the expression of BMPs (Csiszar et al. 
2005). As BMPs are released from osteoclasts they attach to the BMPRI and II receptors 
on pericytes causing these to differentiate into osteoblasts (Zhao et al. 2009) and begin 
depositing new bone. In osteoblasts, the cAMP response element-binding protein (CREB)-
transcription factor is activated by cyclic adenosine monophosphate (cAMP) (Zhang et al. 
2011), as initiated by BMPs, which then transcribes various genes including BMP-2 
(Zhang et al. 2011). However when investigating these pathways it was found that both the 
RANK-L pathway and BMP-cAMP-CREB pathway require Ca
2+
. RANK-L, through 
various signalling intermediaries activates the downstream effector nuclear factor kappa B 
(NF-κB). For this transcription factor to successfully activate the transcription of relevant 
genes, including BMP-2, and hence affect the differentiation of osteoclasts, it is required to 
form a complex with the Nuclear factor of activated T-cells cytoplasmic 1 (NFATC1). 
NFATC1 is the downstream phosphorylated protein activated from the successful activation 
of calmodulin by Ca
2+
. Calmodulin is only activated provided there is sufficient Ca
2+
 
present in the cytoplasm of the cell as was shown by Zyzafoon (2009).  
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Osteoblast differentiation (Fig. 2) and its accompanying gene expression program rely on 
the successful activation of cAMP. cAMP requires phosphorylation via a downstream 
activated kinase, through the successful activation of a membrane bound receptor, the 
BMPR. Furthermore, cAMP requires that the concentration of calcium ions within the 
cytosol of these cells be sufficient (Barbado et al. 2009). If the Ca
2+
 is too low within the 
cytosol it prevents the activation of cAMP even when cAMP has been phosphorylated 
(Barbado et al. 2009). If cAMP is successfully activated the CREB transcription factor is 
phosphorylated permitting the expression of genes and especially that of BMP-2. A loss in 
BMP-2 expression prevent bone formation (Bais et al. 2009) as BMPs have long been  
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Figure 1. The RANK/RANKL pathway. RANKL binds and activates RANK receptor, which 
activates the formation of the NF-κB and inactive calmodulin. Calmodulin becomes fully active 
only when calcium binds to it. Calmodulin activates NFATC1 which in turn forms the 
transcriptional complex with NF-κB. This transcription factor then activates various gene targets. 
(Constructed from material provided in Dougall et al. 1999; Cisiszar et al. 2009, Zyzafoon 2009; 
Zhang et al. 2011). 
 84 
CHAPTER 6: Summarising Discussion 
shown to be involved in the induction of bone formation (Wang et al. 1988; Wang et al. 
1990; Reddi 2000; Ripamonti 2006).  
Results of the present study clearly reiterate this, as a decrease in calcium ion migration in 
verapamil treated bioreactors reduced the level of BMP-2 expression which culminated in 
reduced bone formation by induction. The expression of BMP-2 seems to be able to 
maintain the differentiation of both osteoblasts and osteoclasts (Klar et al. 2013), only if 
there is sufficient Ca
2+
 within the cytosol of target cells. Hence the findings points to the 
importance of Ca
2+
 not just for the formation of new bone, but for cellular differentiation 
and for the successful signaling of BMP responsive pathways required for bone formation.  
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Figure 2. The BMP-2 – cAMP – CREB  pathway.  cAMP pathway is activated upon BMP-2 
binding to the BMP receptor (BMPR). This association phosphorylates and activates cAMP. Only 
in the presence of calcium ions does cAMP become fully active. cAMP then actives CREB which 
in turn forms binds CRE promoter elements of CRE responsive genes. (Constructed from material 
provided in Barbado et al. 2009; Bais et al. 2009) 
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Ripamonti et al. 2010 and Klar et al. (2013) have shown the importance of calcium ions 
and osteoclasts within the bone induction cascade as initiated by implantation of coral-
derived macroporous constructs.  
A subsequent interesting phenomenon observed in all the studies using coral-derived 
macroporous constructs was that the induction of bone formation within coral-derived 
macroporous constructs occurs via the intramembraneous ossification process (Ripamonti 
et al. 2010; Klar et al. 2013) instead of progressing through a cartilage anlage as is the case 
for endochondral bone formation (Gilbert 2000). This trend seems to be conserved 
throughout all experiments that involve biomimetic osteoinductive devices and 
furthermore is not restricted to the site of implantation (Habibovic et al 2006). Why bone 
formation takes the direct route of bone formation instead of the cartilaginous pathway is 
still unclear. Perhaps, as Ripamonti (1991; Ripamonti 1993) suggested, it may be because 
of mesenchymal condensation at the hydroxyapatite interface that prevent cartilage 
formation, instead favoring direct ossification; or as the present study also showed, 
especially through the extensive Collagen Type IV expression at day 15 (Klar et al. 2013), 
that the highly vascularized network that forms within the spaces of the coral-derived 
devices, creates an inhibitory microenvironment that antagonizes chondrogenesis. 
Whatever the reason may be, future research might be necessary to clarify this aspect as it 
may enhance the inductive activity of biomimetic devices. 
6.2 TGF-β3: modulation and initiation of bone formation by induction 
Mammalian TGF-β isoforms have been shown to induce bone formation when combined  
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with coral-derived and collagen matrices implanted in heterotopic extraskeletal sites of 
non-human primates by influencing BMP related gene expression (Ripamonti et al. 1997; 
Ripamonti et al. 2000; Ripamonti et al. 2008). However, a key question regarding the 
induction of bone formation by the TGF-β isoforms, especially the mammalian TGF-β3 , as 
suggested by Ripamonti et al. (2008; 2010), was whether TGF- β3 is directly inducing 
bone formation or acting as a modulator by expressing BMPs/OPs ultimately responsible 
for the induction of bone formation.  
The results of the present study demonstrate that the induction of BMP-2 expression in 
association with the downregulation of Noggin corresponds to the induction of bone in 
heterotopically implanted bioreactors pre-loaded with doses of the hTGF-β3 isoform. 
Therefore hTGF- β3 signaling induces bone formation by regulating Noggin and BMP 
activity and hence the induction of bone formation. A simultaneous application of the 
hNoggin with hTGF-β3 significantly inhibited bone formation compared to the hTGF-β3 
pre-treated devices. The administration of hNoggin severely inhibits morphogenesis by 
perturbing tissue patterning and the collagenous condensations so vital for the bone 
induction process.  
TGF- β3 is an essential regulator of mesenchymal fate controlling early osteoblastic cell 
differentiation (ten Dijke et al. 1990; Shi et al. 2003). All three mammalian TGF-β‟s are 
important for the proliferation, differentiation and commitment of bone progenitor cells. 
Signalling takes place through Smad 2/3 and TAK1-MMK-p38 with BMP-2, -4, -5, -6 and 
-7 acting as inducers in this pathway (Matsunobu et al. 2009; Bandyopadhyay et al. 2006). 
An important and unexplored observation is the apparent loss of TGF-β3 expression on day  
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15 in the hNoggin treated devices which is indicative of the complex relationships of BMP 
and TGF-β expression in the context of bone induction. 
In contrast, BMP-2 has been shown to independently signal through type I and II BMP and 
ALK2 receptors resulting in activation of the Smad1/5/8 pathway (Zhou et al. 2010). Both 
the BMP and TGF-β signalling pathways converge to activate expression of the master 
osteogenesis regulator RUNX-2 (Pretheeban et al. 2012). It is recognized that during bone 
formation there is considerable cross talk between the regulatory pathways where TGF-β 
interacts with the Wnt, FGF and pituitary hormone (PTH) pathway, whilst BMP interacts 
with Notch, FGF and Wnt signaling pathways (Chen et al. 2012). Clearly the modulations 
of the activities of the members of the TGF-β supergene family is very complex and are 
controlled by a range of gene products which include Noggin (Cooper et al. 2009). 
The complexities in the dynamics of bone formation are clearly illustrated in the TGF- β3 
treated macroporous constructs (Klar et al. 2014). On day 15, hTGF- β3 downregulates 
BMP-2 expression. Recent studies in isolated primary human osteoblasts has also shown 
the impact of TGF- β treatment on BMP-2 and -7 with both genes showing a significant 
inhibition of expression through modulation of the Smad 1/5/8 pathway (Ehnert et al. 
2010; Ehnert et al. 2012).  
Endogenous TGF- β3 acting upstream to BMPs appears to be an important controller of the 
rate of bone formation as it is seen to greatly affect RUNX-2 and thus Osteocalcin (OC) 
gene expression (Klar et al., 2014). TGF- β3 also regulates the differentiation of progenitor 
mesenchymal stem cells into the osteoblastic lineage by regulating inductive and inhibitory 
signals (such as Noggin) through the osteoblastic differentiation markers, RUNX2 and OC.  
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Results from this study clearly show an increased percentage of bone that had formed in 
both the TGF-β3 and TGF-β3 /Noggin treatment groups (Klar et al. 2014) together with the 
concomitant decrease in the expression of the inhibitor Noggin.  
This rapid induction of the bone differentiation when the exogenously applied hTGF-β3, in 
combination with the coral-derived macroporous construct, is inserted in the intramuscular 
sites of Papio ursinus was shown morphologically on day 30 with extensive vascular 
invasion and increased osteoblast muticellularity and accompanied by a marked increased 
expression of the Collagen type IV, OC and RUNX-2 genes already by day 15.  
The rapid induction of bone induction by the hTGF- β3 is further illustrated 
morphologically by the induction of bone well outside the border of the implanted 
bioreactors and a distinctive lack of bone formation in the central regions. It has been 
hypothesized that the induction of bone in areas surrounding the device may be due to the 
desorption of the morphogen from the construct with the subsequent diffusion and activity 
into the extracellular microenvironment (Ripamonti et al. 1997). What follows is the rapid 
recruitment of responding cells with the peripheral microenvironment, structural 
organization of the matrix and possibly reprogramming of resident myoblastic and 
pericytic cells into functional osteoblasts. The hTGF-β3, together with the other 
mammalian TGF-β isoforms, could be a novel viable molecular signal to induce bone 
formation in man. The rapid and prominent induction of bone formation has been 
translated in clinical context (Ripamonti et al. 2012a; Ripamonti and Ferretti 2012). 
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This research sought to clarify which molecular signals, cellular mechanisms, morphogens 
and/or genes initiate and modulate the bone induction cascade to expand the current 
paradigm of bone formation by auto induction in the primate Papio ursinus.  
Firstly, this study was directed at establishing the key signals, initiators and modulators of 
the spontaneous induction of bone formation when coral-derived macroporous constructs 
are implanted heterotopically in the rectus abdominis muscle of Papio ursinus. The first 
critical signal is calcium ions which are released from the implanted construct and migrate 
across their relevant voltage-gated ion channels of responding cells. Without calcium ions 
present in the cytoplasm of responsive cells, vital downstream signals of both the BMP and 
TGF-β pathways including important regulatory transcription factors associated with bone 
formation, are not properly activated. Therefore, perturbation of Ca
2+
 ion channelling and 
signalling has an impact on bone formation. Osteoclastogenesis is the cellular mechanism 
and a response that requires the presence of calcium to be initiated. Osteoclastogenesis is 
responsible for the progression of new bone formation by geometrically configuring the 
biomimetic construct to permit osteoblasts to deposit new bone matrix. The geometric 
patterning in combination with the Ca
2+ 
release induces a series of cellular events critical to 
the induction of bone formation, which are angiogenesis, capillary formation and 
differentiation of osteoblasts. The subsequent expression of members of the BMP family, 
and the resultant gene products of BMP signalling, are secreted and embedded in the 
implanted devices inducing the induction of bone formation as a secondary response. 
Secondly, this study has also revealed how hTGF-β3 induces the bone induction cascade in 
the non-human primate Papio ursinus. Findings from this study reiterate that it is the  
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BMPs/OPs, in context the BMP-2 gene activation, that in part initiate bone formation in 
coral-derived macroporous constructs. However, it is hTGF-β3 that initiates bone formation 
by modulating the expression of BMP-2 via Noggin and by regulating the differentiation of 
progenitor mesenchymal stem cells into the osteoblastic lineage, respectively. hTGF-β3 is 
also responsible for the rapid and potent induction of bone suggesting that at the highest  
non-inhibitory dose, hTGF-β3 could reduce the time at which bone induction is initiated 
and increase the rate of the newly formed bone. These finding demonstrate why the 
mammalian hTGF-β3 isoform should be considered for future clinical applications to 
regenerate bone in humans.  
The combined morphological and molecular data analyses and evaluation have indicated 
that hTGF-β3 significantly upregulated RUNX-2 and Osteocalcin expression on day 15 
controlling the differentiation of progenitor stem cells into the osteoblastic lineage. The 
induction of bone as initiated by the hTGF-β3 in the rectus abdominis muscle of Papio 
ursinus is via the BMPs pathway with hTGF-β3 controlling the induction of bone formation 
by regulating the expression of BMPs via Noggin expression. The presented data 
unequivocally demonstrated that hTGF-β3 elicits bone induction by up-regulation of 
endogenous BMP-2 and is blocked by hNoggin. 
On day 15, harvested hTGF-β3 bioreactors show advancing extracellular matrix rings that 
provide structural anchorage for hyper chromatic cells interpreted as differentiating 
osteoblasts reprogrammed by the hTGF-β3  from invading myoblastic/pericytic 
differentiated cells (Klar et al. 2014; Ripamonti et al. 2014).  
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RUNX-2 and Osteocalcin are significantly upregulated in hTGF-β3 treated bioreactors on 
day 15 supporting the morphological observations of invading cell differentiating into the 
osteoblastic phenotype with hyper cellular osteoblastic activity and extracellular matrix 
secretion (Klar et al. 2014; Ripamonti et al. 2014). 
The rapid induction of bone formation by the hTGF-β3 in Papio ursinus has been translated 
in clinical contexts to regenerate severe mandibulo-facial defects in human patients 
(Ripamonti and Ferretti 2012; Ripamonti et al. 2012; Klar et al. 2014). 
The manipulation and rapid induction of a pluripotent stem cell niche harboured in primate 
striated muscle engineering microenvironments super activated by hTGF-β3 
reprogramming recruited differentiated pericytes into highly active secreting osteoblasts in 
primate striated muscle (Ripamonti et al. 2014) with RUNX-2, Osteocalcin, TGF-β3, BMP-
2 and OP-1 expression together with angiogenesis, hyper cellular osteoblastic activity, and 
osteoid synthesis are the novel molecular and morphological basis for the induction of 
bone formation in clinical contexts (Ripamonti et al. 2008; Klar et al. 2014; Ripamonti et 
al. 2014).   
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APPENDIX B      RNA Integrity Numbers (RIN) for all samples 
(Please note that samples are labelled according to animal number, days in vivo and 
treatment type e.g. 001 90d Solo or 001 90d Noggin = Animal number 001, specimen 
left 90 days in vivo, untreated or treated with Noggin...) 
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